Legislation proposing transparency and oversight of the 340B drug discount program was passed May 17 by the House Energy and Commerce Committee’s Subcommittee on Health. The bill, H.R. 3290, will now advance to the Senate.
Read the full post on Becker's Hospital Review - Healthcare News
